Abstract
Research on cancer stem cells—one of the hottest topics in stem cell research—is being revved up with a 3-year agreement between the California Institute for Regenerative Medicine (CIRM) and Canada's newly formed Cancer Stem Cell Consortium, a group of public and private research agencies. California and Canada, which together do 70% of all research on cancer stem cells, want to generate some synergy by teaming up. So the consortium is putting up $100 million for Canadian researchers who collaborate with researchers in California. CIRM, meanwhile, which has been gearing up to support applied stem cell research, will devote a portion of the $122 million in disease-related grants to be awarded to California scientists next year to collaborative cancer stem cell research with Canadian scientists. Mick Bhatia, director of McMaster University's Stem Cell and Cancer Research Institute in Hamilton, Canada, says Canadian and California researchers will meet in workshops soon to discuss how to “leverage and complement each other's work.”
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
